Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Clinical trial Intelligence for contract research organizations

We help CROs win business and enhance drug development services. Make better-informed decisions while bidding on and implementing clinical trials.

The key to trial success

There are some trials that could be great for your business and others that might not be. But without high-quality intelligence, it can be hard to assess or maximize a trial’s potential.

How we help
Our thorough and extensive clinical trial intelligence for CROs will help your organization:

Identify clinical trials that may be completing, as well as company’s planned clinical trials
Make the right go/no-go decision
Design clinical trials that eliminate the need for additional trials, avoiding extra costs
Quickly identify and generate your short list of investigators

We’ll help you identify companies active in your territory and their phases of development. Spot where to run trials, with our data on where comparator trials have been approved and the availability of regional investigators.

You can size up competing trials, because we monitor and benchmark them, prioritizing investigators and tracking enrollment. And to help you mitigate risks, we can provide intelligence on safety issues faced by trials of similar designs.

Our unique strengths

Position your organization to win more business

Helping with everything from lead generation to targeting, proposal preparation to feasibility assessments and bid defenses, our intelligence will help you secure more successful trials.

Find trial-experienced investigators globally

Use the industry’s best source for checking investigator availability in regions, as well as prioritizing and targeting investigators with the right trial experience.

Set your trials up for approval

Shorten the timeline to protocol submission and approval with our clinical trials research and intelligence.

Make better informed decisions

Use our intelligence to inform the design of your clinical trials, bringing efficiencies to the process.

Benefit from a dedicated service

Our services come with dedicated client service and analyst support.

View more
View Less

Relevant products

Citeline

Pharmaprojects: track pharma R&D

The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.

Key benefits:

Curated by experts
Drug R&D landscape
Historical trends

Sitetrove: Clinical trial site & investigator identification

Approximately 400,000 investigators in over 170 countries, all with clinical trial experience, all at your fingertips. Support your trial success and inform your principal investigator (PI) and site selection activities with Sitetrove, now on a sleek, modern interface for simpler, faster and more efficient searching.

Key benefits:

Investigator prioritization
Epidemiology dashboard
Custom tables and charts

View all content

Trialtrove

Trialtrove's Patient-centric Trials Snapshot

24 Oct 2019

Review the trends, diseases, sponsors and outcomes involved with recent patient-centric clinical trials.

Topic Clinical trials

View infographic
Trialtrove

Snapshot of the patient-centric trial landscape

24 Oct 2019

Patient-centric trials have been growing for years. Backed by data from Citeline’s Trialtrove, our latest infographic reveals the trends, the sponsors, and the impact on outcomes around Phase I, II, and III industry-sponsored, patient-centric trials.

Topic Drug development landscape

View infographic
Trialtrove

Trialtrove 2018 Clinical Trials Roundup Surveying the Landscape of 2018 Trial Starts infographic

11 Oct 2019

A clear view of the past is often the surest way to plan for the future. The annual analysis of Phase I-III clinical trials from Citeline’s Trialtrove reveals the priorities and strategies of the biopharma industry. This infographic lets you clearly see the players, trials, and trends.

Topic Drug development landscape BioPharmaceutical Business strategies

View article
Trialtrove

2018 Clinical Trials Roundup: Surveying the Landscape of 2018 Trial Starts

11 Oct 2019

See last year’s clinical trial activity through the eyes of our expert analysts and get a better sense of where the industry is headed. This new whitepaper is the annual analysis of Phase I-III clinical trials, from Citeline’s Trialtrove, and reveals the priorities and strategies of the biopharma industry.

Topic Drug development landscape BioPharmaceutical Business strategies

View article
Citeline

Exploring Basket and Umbrella Oncology Trials

26 Sep 2019

To increase flexibility and efficiency in drug development, master protocols have emerged as an innovative clinical trial design, including basket and umbrella trials. Learn more about how these approaches are being used within oncology research through an overview of the clinical landscape, trial outcomes and trends.

Topic Drug development landscape

View infographic
Citeline, Pink Sheet

Clinical Trial Design Report

26 Sep 2019

Rising costs, patient recruitment issues, shifting regulations, and more are making bringing new drugs to market more difficult than ever. Explore changes in clinical trial design being adopted in response to these challenges with reporting from Pink Sheet.

Topic Drug development landscape

Single report
Citeline

QIDP: What have we GAINed?

By Jonathan Slater 02 Sep 2019

The Generating Antibiotic Incentives Now (GAIN) Act passed into law on July 9, 2012. Seven years on, we review the drugs that have obtained QIDP status, the companies involved, and the clinical trial landscape.

Topic Drug development landscape Drug review

Single report
Trialtrove

Trialtrove 2018 Completed Clinical Trials Snapshot

12 Aug 2019

Get a visual snapshot of how the industry pipelines are faring with our 2018 Completed Trials snapshot. This graphic analysis paints a clear picture of the state of clinical trial completions, while pointing to some important changes that are emerging.

Topic Clinical trials Drug development landscape

Single report
Trialtrove

2018 Completed Trials: State of Industry-Sponsored Clinical Development

06 Aug 2019

The landscape of trials initiated by industry sponsors is one metric that informs about the R&D health of the biopharma industry. Looking specifically at trial completions adds a layer of granularity to the trials landscape and provides valuable perspective on how well industry pipelines are faring. As Informa Pharma has done for the past four years, we report the results from our analysis of the landscape of clinical trials completed during 2018.

Topic Drug development landscape

Single report
Citeline

Clinical Trials State of the Industry Report 2019

30 Jul 2019

KNect365 Life Sciences recently conducted a survey into the clinical trial industry at its most interesting point to date, as organisations are implementing new technologies and trends such as AI, virtual trials and wearables. The final report, based on 214 responses, reveals unique insights into what current benefits and challenges companies are facing in the processes of applying these new approaches to therapeutic development. Citeline introduces the report, exploring what some of the key takeaways mean for the industry.

Topic Drug development landscape

Single report
Citeline

Taking the High Out of Pain: Exploring Abuse-Deterrent Opioids and Opioid Alternatives

03 Jul 2019

With opioid abuse and deaths in the US at an all-time high, the journey to battle the opioid epidemic continues – keeping drug companies and the FDA working hard to come up with effective alternatives for pain.

Topic Drug approval Drug review

View infographic
Citeline, Pharmaprojects

New Active Substances (NAS) LAUNCHED DURING 2018

02 Jul 2019

For a snapshot of the new active substances (NAS) successfully launched last year, download the data-packed New Active Substances (NAS) Launched During 2018 infographic from Citeline.

Topic Drug approval Drug development landscape Drug review

View infographic
Pharmaprojects

Microbiome Modulators for Gastrointestinal Disorders In 2018: Market Overview & The Current Phase I Candidates

02 Jul 2019

The discovery and deep investigation of the microbiome has been one of the most significant recent biomedical advances. Extensive research suggests that dysbiosis of the gut microbiome plays a significant role in multiple gastrointestinal (GI) disorders such as; Crohn’s disease, ulcerative colitis, and irritable bowel syndrome (IBS).

Single report
Citeline, Sitetrove, Trialtrove, Pharmaprojects

Citeline: Global Clinical Trial Intelligence Solutions

02 Jul 2019

Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

Topic Clinical trials Clinical trial optimization

Single report
Citeline

A Decade in Review: Oncology Trial Benchmarks and Sponsor Analysis

By Christine Blazynski, PhD 25 Jun 2019

The average cost of bringing a new drug to market continues to rise, with varying levels of investments across the highly competitive biopharmaceutical industry. To assess the potential effect of varying investments on trial activity and operations, this article reviews trial benchmarks within the active oncology therapeutic area. Industry-sponsored clinical trials across all oncology indications covered by Informa Pharma Intelligence’s Trialtrove were assessed, comparing metrics by company size based on pharma sales, and the identical benchmarks for breast cancer and rare cancers were also analyzed.

Topic Clinical trials Cancer

View white paper

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Clinical trial Intelligence for contract research organizations

The key to trial success

Our unique strengths

Position your organization to win more business

Find trial-experienced investigators globally

Set your trials up for approval

Make better informed decisions

Benefit from a dedicated service

Relevant products

Below are the Product List

Citeline

Pharmaprojects: track pharma R&D

Sitetrove: Clinical trial site & investigator identification

Pharma Intelligence latest insights

Trialtrove's Patient-centric Trials Snapshot

Snapshot of the patient-centric trial landscape

Trialtrove 2018 Clinical Trials Roundup Surveying the Landscape of 2018 Trial Starts infographic

2018 Clinical Trials Roundup: Surveying the Landscape of 2018 Trial Starts

Exploring Basket and Umbrella Oncology Trials

Clinical Trial Design Report

QIDP: What have we GAINed?

Trialtrove 2018 Completed Clinical Trials Snapshot

2018 Completed Trials: State of Industry-Sponsored Clinical Development

Clinical Trials State of the Industry Report 2019

Taking the High Out of Pain: Exploring Abuse-Deterrent Opioids and Opioid Alternatives

New Active Substances (NAS) LAUNCHED DURING 2018

Microbiome Modulators for Gastrointestinal Disorders In 2018: Market Overview & The Current Phase I Candidates

Citeline: Global Clinical Trial Intelligence Solutions

A Decade in Review: Oncology Trial Benchmarks and Sponsor Analysis

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store